Literature DB >> 4043556

Pyruvate dehydrogenase activity in cardiac mitochondria from genetically diabetic mice.

T H Kuo, F Giacomelli, J Wiener, K Lapanowski-Netzel.   

Abstract

Pyruvate dehydrogenase (PDH) was studied in isolated heart mitochondria from genetically diabetic mice (C57BL/KsJ db/db) with progressive cardiomyopathy. Both the basal activity (active enzyme) and the total activity (the sum of active and inactive enzyme) were determined. In mitochondrial extracts from 8-18-wk-old db/db mice, there was a 73% decrease of basal activity accompanied by a 38% decrease of total activity as compared with controls. The lower basal activity at 8 wk of age suggests an increased conversion of the enzyme into the phosphorylated (inactive) form. Evidence is also given that the conversion of inactive (phosphorylated) enzyme into active (dephosphorylated) enzyme is inhibited in cardiac mitochondria prepared from 8-wk and older db/db mice. These changes coincide with the onset of defective oxidative metabolism and can explain the depressed pyruvate oxidation reported previously.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043556     DOI: 10.2337/diab.34.11.1075

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  2 in total

1.  A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.

Authors:  Cheng-Yang Wu; Santhosh Satapati; Wenjun Gui; R Max Wynn; Gaurav Sharma; Mingliang Lou; Xiangbing Qi; Shawn C Burgess; Craig Malloy; Chalermchai Khemtong; A Dean Sherry; David T Chuang; Matthew E Merritt
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

2.  Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R.

Authors:  Jozaa Z ALTamimi; Mona N BinMowyna; Nora A AlFaris; Reham I Alagal; Attalla F El-Kott; Ammar M Al-Farga
Journal:  Saudi Pharm J       Date:  2020-12-14       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.